Antony Newton

Antony Newton is an experienced leader in commercial development and innovative technology introduction for research applications. He is known for driving change and growth in industries such as pharma/biotech and research products and services, with success stories ranging from start-ups to mature organizations. Antony brings a wealth of international and cross-cultural experience, particularly in the US and EU markets.

Antony's educational background includes a FIMLS (BS) in Medical Laboratory Sciences from City of Westminster College, a DMS in Business from Anglia Ruskin University, and an MS in Applied Immunology from Brunel University London.

Antony Newton has held key roles in several reputable organizations. He served as Vice President of Business Development at Inivata. Previously, he worked as a Strategic Advisor in Pharma at Mission Bio and Natera. Antony also held leadership positions such as Senior Vice President of Pharma Partnering and Chief Commercial Officer at Personal Genome Diagnostics. His tenure at Genzyme included roles like Vice President of Portfolio/Process Management and Vice President of Program Management in the Transplant Oncology and Oncology divisions. Antony's career also features diverse roles at Genzyme, Enzymatix, Sigma-Aldrich, and Amersham International, where he managed various business and product functions.

Antony Newton's professional journey includes noteworthy positions such as Chief MLSO at Addenbrooke's Hospital and Senior Medical Laboratory Scientific Officer at the University of London. His vast experience and expertise make him a sought-after consultant and advisor in the industry.